Skye Bioscience, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -187 | -177 | -175 | -65 |
EBITDA | -17,434 | -10,922 | -9,618 | -3,541 |
EBIT | -17,621 | -11,099 | -9,793 | -3,606 |
Net Income | -17,624 | -11,103 | -9,746 | -3,898 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | 9,171,854 | -9,191,792 | -8,223 | -6,781 |
Cash | 23,838 | 46,421 | 68,415 | 67,412 |
Basic Shares | 39,659 | 39,652 | 39,969 | 38,819 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -298 | -124 | -114 | -34 |
EBITDA | -25,509 | -36,610 | -18,574 | -7,716 |
EBIT | -25,807 | -36,734 | -18,689 | -7,750 |
Net Income | -26,567 | -37,645 | -19,482 | -8,522 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,841 | -13,964 | -12,772 | -6,565 |
Cash | 68,415 | 1,256 | 1,244 | 8,983 |
Basic Shares | 36,487 | 7,006 | 493,654 | 1,654 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.44 |
2025-03-31 | -$0.28 |
2024-12-31 | -$0.29 |
2024-09-30 | -$0.10 |
